Loading Events

Go Back

event image

Expert Forum on Chronic Lymphocytic Leukemia – Dallas, TX

July 26 - 27, 2019


Coming soon…

Download our Brochure


  • Debate the rapidly expanding information on molecular diagnostics, genomic analysis, new molecular targets, and the evolution of care over the next five years of CLL treatment
  • Deliberate risk assessment and integration of MRD into clinical trials
  • Debate BTK, PI3K, and BCL2 inhibitors and how they can be used in combination therapy, how to prevent resistance, and
  • how emerging inhibitors compete
  • Explore the role of CAR-T cells therapy in CLL
  • Discuss the integration of novel therapies, including checkpoint inhibitors, antibody drug conjugates, and bispecific
  • antibodies, into the current treatment paradigm
  • Explore new targets in development for CLL